we can only take the CEO word on facevalue if he is flat out lying and misleading market about several top 20 pharma companies signing a non disclosure confidentiality agreement then it will only be his downfall and he will likely be sacked.
either way at current MC this is definitely worth a punt. several biotechs not even remotely as advanced as 1AD are on several multiples of 1AD MC.
there was 100M shares that traded when ann and there has been healthy buying whenever it dips so obviously plenty see upsides.
Ann: Corporate Presentation, page-81
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.001(4.17%) |
Mkt cap ! $13.32M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $48.90K | 1.864M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 312000 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 71000 | 1 |
View Market Depth
| Last trade - 13.43pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.5¢ |
Change
0.001 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 2.5¢ | 2.7¢ | 2.4¢ | 616201 | ||
| Last updated 15.57pm 21/05/2024 ? | |||||
| 1AD (ASX) Chart |